HOUSE 2064116th CongressSubcommittee Hearings Held.

To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.

Last Action: 5/21/2019

Actions

2019-05-21Subcommittee Hearings Held.
2019-04-04Referred to the Subcommittee on Health.
2019-04-03Referred to the Subcommittee on Health.
2019-04-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-03Introduced in House
2019-04-03Introduced in House

CRS Summary

As of 2019-04-03 (00)

This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

Cosponsors (1)

Devin Nunes (R-CA)

Subjects

Consumer affairs
Government information and archives
Health technology, devices, supplies
Inflation and prices
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.